¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦47ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦47ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-24
±³À°ÀÏÀÚ : 2019-11-24
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï ºñ½ºÅ¸È¦ ±×·£µåȦ  
±³À°ÁÖÁ¦ : Á¦47ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ
´ã´çÀÚ : ÇãÁö¼±
¿¬¶ôó : 02-3147-0930  
À̸ÞÀÏ : kse0930@ksecho.org      
±³À°Á¾·ù : ³»°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 1200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í [»çÀü-(°³¿ø)Àü¹®ÀÇ,ÀüÀÓÀÇ,±ºÀÇ°ü µî 8¸¸¿ø / Àü°øÀǹױ⟠4¸¸¿ø] [ÇöÀå-(°³¿ø)Àü¹®ÀÇ,ÀüÀÓÀÇ,±ºÀÇ°ü µî 10¸¸¿ø / Àü°øÀǹױ⟠6¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:00~08:10 Case 1 Presentation  ±è´ëÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:10~08:25 KSTCVS: Why Do We Have to Undergo SAVR  À̽ÂÇö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:25~08:40 KSIC: TAVR Is Best Option for This Patient  ¹Ú´ö¿ì(¿ï»êÀÇ´ë) 
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 08:40~08:45 Panel Discussion  () 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:45~08:55 Case 2 Presentation  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:55~09:10 KSTCVS: Why Do We Have to Undergo SAVR  À̽ÂÇö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 09:10~09:25 KSIC: TAVR Is Best Option for This Patient  ¹Ú´ö¿ì(¿ï»êÀÇ´ë) 
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 09:25~09:30 Panel Discussion  () 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 10:30~10:45 Long-term Survival of Asymptomatic Patients with Very Severe Aortic Stenosis Early Surgery versus Conventional Treatment  À̽¾Æ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 10:45~11:00 Diffuse myocardial fibrosis and diastolic dysfunction in aortic stenosis  ÀÌÇöÁ¤(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 11:00~11:15 Prognostic Value of Left Ventricular Global Longitudinal Strain during Dobutamine Stress Echocardiography in Patients with Low-flow Low-gradient Severe Aortic Stenosis  ±è´Ù·¡(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 11:15~11:30 Characteristics of Left Atrial Mechanical Function in Subjects with Mitral Annular Calcification A study with 2D and 3D speckle tracking echocardiography  ÃÖÀÚ¿¬(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 11:30~11:45 Fate of Non-dysfunctional Bicuspid Aortic Valve With or Without Aortopathy Insight a Large Korean Registry  ¼Û½ÅÁ¤(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 11:45~11:50 Panel Discussion  () 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 13:05~13:30 Recent update on Oral Anticoagulant Therapy  Á¶Àͼº(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 13:30~13:55 Should we deal with adherence in hypertensive patients?  ÀÓÁ¾·¡(Á¾±Ù´ç È¿Á¾¿¬±¸¼Ò) 
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 13:55~14:00 Discussion  () 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 14:00~14:20 Echo Provides More Than We Think  ±è¿ëÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 14:20~14:40 Assessing Left Ventricular Diastolic Function in the Catheterization Laboratory  ÇÏÁ¾¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 14:40~15:00 Growing Evidence of CMR for Hemodynamic Measurement  ±è³²±¹(¿ï»êÀÇ´ë) 
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 15:00~15:20 Panel Discussion  () 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:00~16:15 Update of PH and Evidence-based Treatment Algorithm  ÀåÁ¤À±(°æ»óÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:15~16:30 How to Diagnose and Manage PH Due to Left Heart Disease  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:30~16:45 How to Diagnose and Manage CTEPH  À强¾Æ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:45~17:00 RV & Its Load in Pulmonary Hypertension  ±è¼ºÈ¯(°í·ÁÀÇ´ë) 
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 17:00~17:20 Panel Discussion  () 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:00~08:15 The Use of Contrast Agents for MCE in Cardiomyopathy  Han Wei(The First Affiliated Hosp. of Harbin Medical Univ) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:15~08:30 Advanced Imaging Techniques in Left Atrial Structure and Function  ½Å¼ºÈñ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:30~08:45 Echocardiography for Complication of Mitral Valve Repair  Fei Hongwen(Guangdong Provincial Cardiovascular Institute) 
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:45~09:00 Machine learning in echocardiography, supervised or unsupervised?  À̽ÂÇ¥(¼­¿ïÀÇ´ë) 
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 2 09:00~09:20 Panel Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦47ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2019-11-24
´ÙÀ½±Û ÀÇ·áÁ¤Ã¥¿¬±¸¼Ò ½Å·Ú¹Þ´Â ÀÇ»çÀÇ ÀÇ»ç¼ÒÅë: ȯÀÚ°æÇè : 2019-11-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21030 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (2ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-28 0 5 2024-06-18
21029 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 8 2024-06-18
21028 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-28 0 11 2024-06-18
21027 ºÎ»ê ´ëÇѽÉÀåÇÐȸ ±âÃÊ°úÇבּ¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö 2024 : 2024-06-28 0 6 2024-06-18
21026 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾƳ»ºÐºñÇÐȸ ºñ¸¸¿¬±¸Áý´ãȸ 2024³â 1Â÷ : 2024-06-27 0 7 2024-06-18
21025 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 2 2024-06-18
21024 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 1ÀÏÂ÷ : 2024-06-27 0 6 2024-06-18
21023 ´ë±¸ ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ ´ë±¸°æºÏÁöȸ 3Â÷ Áý´ãȸ : 2024-06-27 0 4 2024-06-18
21022 ¼­¿ï ´ëÇѼҾƸ¶ÃëÇÐȸ ¿Â¶óÀÎ 2024³â Èñ±Í³­Ä¡ Áúȯ ¸¶Ãë ÇÁ·ÎÅäÄÝ ¿þºñ³ª : 2024-06-27 0 6 2024-06-18
21021 ¼­¿ï (1ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-27 0 6 2024-06-18
21020 °­¿ø 2024 ö¿ø±ºÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß(Ä¡¸Å, ¹é³»Àå°ú ³ë¾È) 0 6 2024-06-18
21019 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-27 0 5 2024-06-18
21018 ÀüºÏ ±º»ê½ÃÀÇ»çȸ ¿¬¼ö±³À°(±â´É¼º ¼ÒÈ­ºÒ·®Áõ, º¸Çè½É»çÀÇ ÃֽŠÀ̽´) : 2024-06-27 0 4 2024-06-18
21017 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 10 2024-06-18
21016 ºÎ»ê 2024 ±ÝÁ¤±¸ÀÇ»çȸ Çмú´ëȸ(¿¹¹æÁ¢Á¾, ÇʼöÀÇ·áÆÐÅ°Áö) : 2024-06-27 0 9 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷